Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Selvigaltin

Copy Product Info
🥰Excellent
Hot
Catalog No. T63751Cas No. 1978336-95-6
Alias GB1211

Selvigaltin (GB1211) is a Gal-3 inhibitor with potential anticancer activity. Selvigaltin is used in the study of cirrhosis and cancer.

Selvigaltin

Selvigaltin

Copy Product Info
🥰Excellent
Hot
Purity: 99.49%
Catalog No. T63751Alias GB1211Cas No. 1978336-95-6
Selvigaltin (GB1211) is a Gal-3 inhibitor with potential anticancer activity. Selvigaltin is used in the study of cirrhosis and cancer.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$278In StockIn Stock
5 mg$689In StockIn Stock
10 mg$1,180In StockIn Stock
25 mg$2,380In StockIn Stock
1 mL x 10 mM (in DMSO)$826In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.49%
ee:100%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Selvigaltin AI Summary
Selvigaltin exhibits a diverse range of bioactivities, demonstrating significant pharmacokinetic and pharmacodynamic properties. The compound has a LogD of 3.0 according to shake-flask analysis, indicating moderate lipophilicity. It inhibits various CYP enzymes, including 2C19, 3A4, 1A2, 2C9, 2D6, 2C8, and 2B6, with inhibition constants greater than 10.0 μM, suggesting low potential for CYP-mediated drug-drug interactions at typical therapeutic concentrations. Additionally, Selvigaltin shows selective binding affinity to different Galectin proteins, indicating possible targeting specificity and potential therapeutic applications. Its permeability across human Caco-2 cells varies between apical to basolateral and basolateral to apical directions, highlighting its absorption characteristics. The compound exhibits variable stability in human and mouse hepatocytes with different clearance rates, and its clearance and oral bioavailability have been confirmed in C57BL/6 mice, providing essential pharmacokinetic insights. Moreover, it demonstrates plasma protein binding in both human and mouse plasma, affecting its distribution and free drug concentration. Selvigaltin inhibits the hERG channel at concentrations below 10.0 μM, indicating a need for cardiac safety assessment. It also displays binding affinity to the rat calcium L channel and the human dopamine transporter, with specific activity percentages, suggesting potential impacts on calcium signaling and neurotransmitter regulation..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Selvigaltin (GB1211) is a Gal-3 inhibitor with potential anticancer activity. Selvigaltin is used in the study of cirrhosis and cancer.
SynonymsGB1211
Chemical Properties
Molecular Weight533.32
FormulaC19H16BrF3N4O4S
Cas No.1978336-95-6
Smiles[H][C@@]1([C@@H](O)[C@@H](CO)O[C@H](Sc2cncc(Br)c2)[C@@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1
Storage & Solubility Information
Storagekeep away from direct sunlight,store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 265 mg/mL (496.89 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+90% Corn Oil: 1 mg/mL (1.88 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.8750 mL9.3752 mL18.7505 mL93.7523 mL
5 mM0.3750 mL1.8750 mL3.7501 mL18.7505 mL
10 mM0.1875 mL0.9375 mL1.8750 mL9.3752 mL
20 mM0.0938 mL0.4688 mL0.9375 mL4.6876 mL
50 mM0.0375 mL0.1875 mL0.3750 mL1.8750 mL
100 mM0.0188 mL0.0938 mL0.1875 mL0.9375 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Selvigaltin | purchase Selvigaltin | Selvigaltin cost | order Selvigaltin | Selvigaltin chemical structure | Selvigaltin formula | Selvigaltin molecular weight